The French Senior health authority is set to advise the government to remove reimbursement for 145 drug products

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.516, 2006-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hospital Reimbursement Price Cap for Cancer Drugs: The French Experience in Controlling Hospital Drug Expenditures

By Degrassat-Théas A.

PharmacoEconomics, Vol. 30, Iss. 7, 2012-07 ,pp. : 565-573

Adis International

Access to resources Recommend Favorite

Reform of Prescription Drug Reimbursement and Pricing in the German Social Health Insurance Market: A Comparison of Three Scenarios

By Greß Stefan

PharmacoEconomics, Vol. 25, Iss. 6, 2007-01 ,pp. : 443-454

Adis International

Access to resources Recommend Favorite

Drug reimbursement reduction annulled in France

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 424, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

New drug listings for reimbursement in New Zealand

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 352, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Reimbursement decision for drotrecogin alfa, drug-eluting stents

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 375, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite